Xtant Medical Holdings, Inc.

AMEX:XTNT

Medical - Devices

Healthcare
$0.36 -0.16%

-$0.00 today

Market cap
$50.37M
Beta
-0.17
P/E (TTM)
33.4
EPS (TTM)
$0.01
52W Low $0.40High $0.95

Volume 0.16M

Average 0.16M

XTNT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Xtant Medical Holdings, Inc.AMEX: XTNT

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 57.3%

Gross margin was 57.3% in Q1 FY2026, down 4.2 pp from a year earlier. On a trailing-twelve-month basis it was 62.3%, up 4.2 pp year over year. Over 3 fiscal years it widened by 7.5 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.3%+2.5 pp QoQ
Last fiscal yearDec 2025
62.9%+4.8 pp YoY
LTMMar 2026
62.3%+4.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.2 pp——
1 year+4.8 pp——
3 years+7.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
62.9%
Year-over-year change
+4.8pp

Gross Margin vs competitors

How XTNT compares with its peers on the latest reported figures

  • XTNT's LTM Mar 2026 gross margin of 62.3% is the 2nd highest of the 6 companies compared; the peer median is 32.3%.
  • Its year-over-year change of +4.2 pp is the 3rd highest of 6, against a peer median of -1.0 pp.
  • Over three fiscal years its change of +7.5 pp compares with a peer median of -0.3 pp.
XTNT Competitors Peer median
Gross Margin for XTNT and competitors
Company Period LTM level YoY 3-year change
RCELAVITA Medical, Inc.LTM Mar 202681.4% -4.1 pp-0.3 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 202662.3% +4.2 pp+7.5 pp
FONRFONAR CorporationLTM Mar 202640.3% -1.0 pp-7.1 pp
APYXApyx Medical CorporationLTM Mar 202632.3% -19.3 pp-29.4 pp
RPIDRapid Micro Biosystems, Inc.LTM Mar 202612.4% +6.3 pp+72.5 pp
LUCDLucid Diagnostics Inc.LTM Mar 2026-40.0% +27.6 pp+798.4 pp
VANIVivani Medical, Inc.FY2025— ——
EXOZeXoZymes, Inc.FY2025— ——
Peer median (excluding XTNT) 32.3%-1.0 pp-0.3 pp

Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue55.26M57.97M91.3M117.27M133.93M
Cost of Revenue22.77M25.83M35.84M49.05M49.65M
Gross Profit32.49M32.14M55.47M68.22M84.27M
Gross Margin58.8%55.4%60.8%58.2%62.9%
Research & Development870K915K1.34M2.39M2.1M
Selling, General & Admin35.47M37.98M64.29M77.91M74.89M
Operating Expenses36.34M38.89M65.63M80.29M76.99M
Depreciation & Amortization1.34M1.3M3.17M4.22M5.22M
EBITDA(2.51M)(5.43M)5.08M(7.88M)15.9M
EBITDA Margin-4.5%-9.4%5.6%-6.7%11.9%
Operating Income(3.85M)(6.76M)(10.16M)(12.07M)7.28M
Operating Margin-7.0%-11.7%-11.1%-10.3%5.4%
Interest Income031K149K094K
Interest Expense995K1.69M2.94M4.16M3.67M
Other Income / Expenses(995K)(1.66M)9.12M(4.19M)(283K)
Income Before Tax(4.85M)(8.42M)(1.04M)(16.26M)7M
Pre-Tax Margin-8.8%-14.5%-1.1%-13.9%5.2%
Income Tax Expense069K(1.7M)187K2.03M
Net Income(4.85M)(8.49M)660K(16.45M)4.97M
Net Margin-8.8%-14.6%0.7%-14.0%3.7%
EPS (Basic)(0.06)(0.09)0.01(0.12)0.04
EPS (Diluted)(0.06)(0.09)0.01(0.12)0.03
Weighted Avg Shares85.46M94.09M119.09M133.67M139.53M
Weighted Avg Shares (Diluted)85.46M94.09M126.79M133.67M150.04M

Xtant Medical Holdings, Inc.

AMEX:XTNT

Intrinsic Alpha fair value

Locked

Current Price

$0.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.